Kubista E - Search Results

1

Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype.

Singer CF, Kronsteiner N, Hudelist G, Marton E, Walter I, Kubista M, Czerwenka K, Schreiber M, Seifert M, Kubista E. Singer CF, et al. Among authors: kubista m, kubista e. Clin Cancer Res. 2003 Oct 15;9(13):4877-83. Clin Cancer Res. 2003. PMID: 14581361

2

MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.

Singer CF, Kronsteiner N, Marton E, Kubista M, Cullen KJ, Hirtenlehner K, Seifert M, Kubista E. Singer CF, et al. Among authors: kubista m, kubista e. Breast Cancer Res Treat. 2002 Mar;72(1):69-77. doi: 10.1023/a:1014918512569. Breast Cancer Res Treat. 2002. PMID: 12000221

3

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G; Austrian Breast and Colorectal Cancer Study Group. Schindl M, et al. Among authors: kubista e. Clin Cancer Res. 2002 Jun;8(6):1831-7. Clin Cancer Res. 2002. PMID: 12060624

4

Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines.

Hirtenlehne K, Pec M, Kubista E, Singer CF. Hirtenlehne K, et al. Among authors: kubista e. Eur Cytokine Netw. 2002 Apr-Jun;13(2):234-40. Eur Cytokine Netw. 2002. PMID: 12101080 Free article.

5

Brca1 regulates in vitro differentiation of mammary epithelial cells.

Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschläger M. Kubista M, et al. Among authors: kubista e. Oncogene. 2002 Jul 18;21(31):4747-56. doi: 10.1038/sj.onc.1205580. Oncogene. 2002. PMID: 12101413

6

Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.

Jakesz R, Hausmaninger H, Kubista E, Gnant M, Menzel C, Bauernhofer T, Seifert M, Haider K, Mlineritsch B, Steindorfer P, Kwasny W, Fridrik M, Steger G, Wette V, Samonigg H; Austrian Breast and Colorectal Cancer Study Group Trial 5. Jakesz R, et al. Among authors: kubista e. J Clin Oncol. 2002 Dec 15;20(24):4621-7. doi: 10.1200/JCO.2002.09.112. J Clin Oncol. 2002. PMID: 12488405 Clinical Trial.

7

Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.

Schmid M, Jakesz R, Samonigg H, Kubista E, Gnant M, Menzel C, Seifert M, Haider K, Taucher S, Mlineritsch B, Steindorfer P, Kwasny W, Stierer M, Tausch C, Fridrik M, Wette V, Steger G, Hausmaninger H. Schmid M, et al. Among authors: kubista e. J Clin Oncol. 2003 Mar 15;21(6):984-90. doi: 10.1200/JCO.2003.01.138. J Clin Oncol. 2003. PMID: 12637461 Clinical Trial.

8

Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.

Jakesz R, Samonigg H, Gnant M, Kubista E, Depisch D, Kolb R, Mlineritsch B, Mischinger HJ, Menzel RC, Steindorfer P, Kwasny W, Tausch C, Stierer M, Taucher S, Seifert M, Hausmaninger H; Austrian Breast & Colorectal Cancer Study Group. Jakesz R, et al. Among authors: kubista e. Ann Surg. 2003 Apr;237(4):556-64. doi: 10.1097/01.SLA.0000059990.43981.4E. Ann Surg. 2003. PMID: 12677153 Free PMC article.

9

Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors.

Singer CF, Hudelist G, Schreiber M, Kubista E. Singer CF, et al. Among authors: kubista e. Drugs Today (Barc). 2003 Feb;39(2):115-25. doi: 10.1358/dot.2003.39.2.740211. Drugs Today (Barc). 2003. PMID: 12698206 Review.

10

Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.

Hudelist G, Czerwenka K, Kubista E, Marton E, Pischinger K, Singer CF. Hudelist G, et al. Among authors: kubista e. Breast Cancer Res Treat. 2003 Mar;78(2):193-204. doi: 10.1023/a:1022930710850. Breast Cancer Res Treat. 2003. PMID: 12725419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters